Cefurav Plus is a broad-spectrum antibacterial medicine formulated to provide enhanced protection against a wide range of bacterial infections caused by susceptible organisms. Combining the therapeutic effectiveness of a cephalosporin antibiotic with a beta-lactamase inhibitor, it helps overcome bacterial resistance and improves antimicrobial coverage against both Gram-positive and Gram-negative pathogens. Cefurav Plus is commonly indicated for respiratory tract infections, ear, nose and throat infections, urinary tract infections, skin and soft tissue infections, and other community-acquired bacterial conditions. Its bactericidal action works by inhibiting bacterial cell wall synthesis, supporting rapid infection control and clinical recovery. Cefurav Plus plays an important role in modern antibacterial therapy where broader coverage and resistance protection are clinically required.